Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H28N4O.ClH |
| Molecular Weight | 352.902 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCN(CCCC)CCNC1=NC(=NO1)C2=CC=CC=C2
InChI
InChIKey=ZCEDBAQIHPGWNW-UHFFFAOYSA-N
InChI=1S/C18H28N4O.ClH/c1-3-5-13-22(14-6-4-2)15-12-19-18-20-17(21-23-18)16-10-8-7-9-11-16;/h7-11H,3-6,12-15H2,1-2H3,(H,19,20,21);1H
| Molecular Formula | C18H28N4O |
| Molecular Weight | 316.4411 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6767648
butalamine-hydrochloride (Adrevil forte) in a daily dosage of 3 x 2 tablets
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:27 GMT 2025
by
admin
on
Mon Mar 31 18:02:27 GMT 2025
|
| Record UNII |
Q7URG335CL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000084838
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY | |||
|
SUB00909MIG
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY | |||
|
42078
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY | |||
|
Q7URG335CL
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY | |||
|
236155
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY | RxNorm | ||
|
m2783
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY | Merck Index | ||
|
DBSALT002903
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY | |||
|
56974-46-0
Created by
admin on Mon Mar 31 18:02:27 GMT 2025 , Edited by admin on Mon Mar 31 18:02:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |